GleamWall
中文EN

GLAS Glass House Brands Inc. Annual reports only

Medicinal Chemicals & Botanical Products · NYSE · SEC CIK 1848731 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-9.4%
TTM net income YoY-5,814.6%
TTM EPS YoY-161.9%
Revenue 3-yr CAGR28.9%
Net income 3-yr CAGR—

Margins

Gross margin42.3%
Operating margin-9.1%
Net margin-16.3%
FCF margin-8.6%
EBITDA margin-0.8%

Returns

ROE-31.2%
ROA-9.4%
ROIC (approx.)-10.2%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets45.2%
Debt / equity0.93x
Current ratio1.78x
Interest coverage-2.34x

Cash quality & payout

Operating cash flow / net income-0.39x
Accruals ratio-13.1%
Payout ratio—
Capex / revenue14.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$181.98M$200.90M$160.84M$84.87M$63.19M
Cost of revenue$105.02M$103.50M$79.87M$64.16M$47.39M
Gross profit$76.96M$97.39M$80.97M$20.71M$15.80M
SG&A expense$64.10M$60.13M$52.91M$45.57M$33.78M
Operating income-$16.53M$5.74M-$49.53M-$56.39M-$36.18M
Interest expense$7.06M$9.18M$9.82M$7.61M$2.74M
Pretax income-$17.02M$11.22M-$88.12M-$37.35M-$41.29M
Income tax$11.93M$10.50M$9.94M-$4.39M$2.01M
Net income-$29.66M$519,000-$98.27M-$32.90M-$43.10M
EBITDA-$1.53M$20.04M-$36.03M-$45.07M-$31.58M
EPS (basic)-0.55-0.21-1.62-0.83-1.11
EPS (diluted)-0.55-0.21-1.62-0.83-1.11
Weighted avg. shares (diluted)81.94M75.23M72.03M64.18M40.28M
Balance sheet
Cash & equivalents$23.35M$36.92M$32.52M$14.14M$54.07M
Receivables$4.42M$5.22M$3.98M$4.79M$2.46M
Inventory$26.23M$14.25M$8.84M$10.95M$6.53M
Current assets$67.75M$66.10M$49.22M$38.89M$68.62M
PP&E, net$228.76M$212.25M$215.69M$216.43M$195.80M
Goodwill—$0$0$37.80M$4.92M
Intangibles$11.58M$14.20M$21.21M$35.92M$5.63M
Total assets$318.56M$310.50M$303.77M$350.63M$287.58M
Current liabilities$37.96M$66.48M$87.36M$54.00M$55.24M
Short-term debt$37,000$7.64M$7.55M$40,237$37,986
Long-term debt$68.63M$50.55M$56.51M$62.62M$44.82M
Total debt$68.67M$58.20M$64.06M$62.66M$44.86M
Total liabilities$143.96M$146.45M$158.54M$129.49M$105.65M
Shareholders' equity$73.94M$116.24M$89.76M$168.86M$182.13M
Net debt$45.32M$21.27M$31.54M$48.51M-$9.21M
Cash flow statement
Operating cash flow$11.45M$28.39M$23.22M-$40.78M-$20.29M
Capital expenditure$27.18M$10.29M$12.31M$27.77M$108.50M
Free cash flow-$15.73M$18.10M$10.91M-$68.55M-$128.78M
Investing cash flow-$27.74M-$10.29M-$12.71M-$29.20M-$111.50M
Financing cash flow$2.72M-$13.70M$7.87M$30.06M$181.32M
Depreciation & amortization$15.00M$14.30M$13.50M$11.32M$4.60M
Stock-based compensation$13.40M$13.10M$7.64M$12.76M$8.71M

Free plan shows the latest 5 periods; Pro shows all 6 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.